Recent Papers on Rhabdomyosarcoma – 20 March 2014
From Google Scholar Alerts
Please note that some are abstracts requiring subscriptions or purchase of the full article, others provide a more comprehensive view of the paper.
Primary Cutaneous Epithelioid Rhabdomyosarcoma: A Rare, Recently Described Entity With Review Of The Literature
PC Feasel, TB Marburger, SD Billings - Journal of Cutaneous Pathology, 2014
Abstract We report a case of a primary cutaneous epithelioid rhabdomyosarcoma that
presented as a single raised pink-purple lesion (3.3 x 2.2 cm) on the left base of neck in a 75-
year-old man. Histopathologic examination revealed an exophytic, nodular tumor within ...
Ceramide inhibits insulin-stimulated Akt phosphorylation through activation of Rheb/mTORC1/S6K signaling in skeletal muscle
CT Hsieh, JH Chuang, WC Yang, Y Yin, Y Lin - Cellular Signalling, 2014
... content. 2.4. Cell culture, differentiation, and transfection. Mice C2C12 myoblasts
and human rhabdomyosarcoma (RD) cells were purchased from the Bioresource
Collection and Research Center (BCRC, Hsinchu, Taiwan). ...
Prognostic implications of ezrin and
phosphorylated ezrin expression in non-small cell lung cancer
T Jin, J Jin, X Li, S Zhang, YH Choi, Y Piao, X Shen… - BMC Cancer, 2014
... More than 90% of deaths from NSCLC are attributable to metastases . The cytoskeletal
organizer ezrin was first identified as an important metastatic regulator in rhabdomyosarcoma
and osteosarcoma [6,7]. Ezrin is a member of the ezrin-radixin-moesin Page 4. ...
Inputs and outputs of insulin receptor
Y Du, T Wei - Protein & Cell, 2014
Page 1. REVIEW Inputs and outputs of insulin receptor Yipeng Du, Taotao Wei &
National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy
of Sciences, Beijing 100101, China & Correspondence: weitt ...
Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39
F Bassilana, A Carlson, JA DaSilva, B Grosshans… - Nature Chemical Biology, 2014
A new small-molecule inhibitor of the Hedgehog signaling pathway acts independently of
Smoothened (Smo). Rather than acting through Smo, which is a GPCR-like protein of the pathway,
the compound acts through the orphan GPCR GPR39, with the level of GPR39 activation ...